Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Kidney International

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/ki.2014.67PMID 24670409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.

  2013cited by this paper
• Epidemiology of diabetic kidney disease.

  2013cited by this paper
• Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis.

  2013cited by this paper
• TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition

  2012cited by this paper
• Increased Expression of Intranuclear Matrix Metalloproteinase 9 in Atrophic Renal Tubules Is Associated with Renal Fibrosis

  2012cited by this paper
• Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

  2012cited by this paper
• Matrix metalloproteinases in kidney homeostasis and diseases.

  2012cited by this paper
• Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review.

  2011cited by this paper
• Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition.

  2011cited by this paper
• Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

  2011cited by this paper
• The role of EMT in renal fibrosis

  2011cited by this paper
• Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β

  2011cited by this paper
• Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

  2011cited by this paper
• MMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.

  2011cited by this paper
• Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury

  2011cited by this paper
• Minocycline with Aspirin: An Approach to Attenuate Diabetic Nephropathy in Rats

  2011cited by this paper
• United States Renal Data System

  2011cited by this paper
• Expression and role of integrin-linked kinase and collagen IV in human renal allografts with interstitial fibrosis and tubular atrophy.

  2010cited by this paper
• Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.

  2010cited by this paper
• Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy.

  2010cited by this paper
• New insights into epithelial-mesenchymal transition in kidney fibrosis.

  2010cited by this paper
• Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.

  2010cited by this paper
• Resolved: EMT produces fibroblasts in the kidney.

  2010cited by this paper
• Matrix metalloproteinases in subjects with type 1 diabetes

  2009cited by this paper
• Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.

  2009cited by this paper
• MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development.

  2009cited by this paper
• Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells.

  2009cited by this paper
• [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].

  2008cited by this paper
• The role of inflammatory cytokines in diabetic nephropathy.

  2008cited by this paper
• Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

  2008cited by this paper
• The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells

  2008cited by this paper
• Diabetic Nephropathy: Mechanisms of Renal Disease Progression

  2008cited by this paper
• Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population

  2008cited by this paper
• Udział metaloproteinaz macierzy w patogenezie cukrzycy i rozwoju retinopatii cukrzycowej* The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy

  2008cited by this paper
• The pathogenesis of diabetic nephropathy

  2008cited by this paper
• Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease.

  2007cited by this paper
• Podocytes in culture: past, present, and future.

  2007cited by this paper
• Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin.

  2007cited by this paper
• Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.

  2006cited by this paper
• High Ambient Glucose Levels Modulates the Production of MMP-9 and a5(IV) Collagen by Cultured Podocytes

  2006cited by this paper
• The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage.

  2006cited by this paper
• Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury

  2006cited by this paper
• Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling.

  2006cited by this paper
• Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

  2005cited by this paper
• Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat.

  2004cited by this paper
• Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance.

  2004cited by this paper
• Pathogenesis of Diabetic Nephropathy

  2004cited by this paper
• Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.

  2003cited by this paper
• Estimating mean glomerular volume using two arbitrary parallel sections.

  2002cited by this paper
• Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases

  2002cited by this paper
• Matrix Metalloproteinase Expression Is Related to Hemorrhagic Transformation After Cardioembolic Stroke

  2001cited by this paper
• Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia

  2001cited by this paper
• The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys.

  2001cited by this paper
• Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function.

  2001cited by this paper
• Morphogenetic activity of extracellular matrices on cultured podocytes. Laminin accelerates podocyte process formation in vitro.

  2001cited by this paper
• Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

  2000cited by this paper
• Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

  2000cited by this paper
• Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase

  1996cited by this paper
• Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

  1996cited by this paper
• Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy.

  1993cited by this paper
• The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy

  1983cited by this paper
• Determination of membrane thickness distribution from orthogonal intercepts

  1979cited by this paper

• Gene Modification: Exploring the potential in treating kidney diseases.

  2026cites this paper
• A theoretical framework for extrapolating Andrographis paniculata mechanisms to the novel CIRDD and IROD diabetes clusters

  2026cites this paper
• Association of GlyCD147 with carotid atherosclerosis: evidence from integrative analyses.

  2026cites this paper
• Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Trigonelline against diabetic nephropathy via targeting MMP9

  2025cites this paper
• Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome

  2025influential citation
• Transcriptomic Approach in Understanding Fabry Nephropathy: A Review of the Literature and Proof-of-Concept

  2025cites this paper
• Diffusion Tensor Imaging Magnetic Resonance Imaging Assessment in a Clinical Trial of Autologous Dendritic Cell Transfer for Diabetic Kidney Disease: A Molecular Approach

  2025cites this paper
• SA4503 Mitigates Adriamycin-Induced Nephropathy via Sigma-1 Receptor in Animal and Cell-Based Models

  2025cites this paper
• The ameliorative effect of lycopene and grape seed proanthocyanidins extract against streptozotocin-induced diabetic nephropathy in rats

  2025cites this paper
• Finerenone prevents renal damage by enhancing SDF-1α/CXCR4-mediated stem cell mobilization in experimental type 1 diabetic nephropathy.

  2025cites this paper
• Investigation on the relationship between renal NONO expression, fibrosis and prognosis in diabetic nephropathy

  2025cites this paper
• Syndecans and diabetic complications: a narrative review.

  2024cites this paper
• Matrix metalloproteinases in kidney homeostasis and diseases: an update.

  2024cites this paper
• CXCL5 inhibition improves kidney function by protecting renal tubular epithelial cells in diabetic kidney disease.

  2024cites this paper
• Human and Mouse Nephrin and Their Interactions With 13 Proteins: An In Silico Study

  2024cites this paper
• Unveiling the bidirectional role of MMP9: A key player in kidney injury.

  2024cites this paper
• Bioflavonoid combination attenuates diabetes-induced nephropathy in rats via modulation of MMP-9/TIMP-1, TGF-β, and GLUT-4-associated pathways

  2024cites this paper
• Association of Serum Unsaturated Fatty Acid Patterns with the Risk of Diabetic Nephropathy

  2024cites this paper
• Exploring the potential mechanisms of Tongmai Jiangtang capsules in treating diabetic nephropathy through multi-dimensional data

  2023cites this paper
• Luteolin attenuates diabetic nephropathy via inhibition of metalloenzymes in rats

  2023cites this paper
• High glucose enhances the activation of NLRP3 inflammasome by ambient fine particulate matter in alveolar macrophages

  2023cites this paper
• Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes

  2023cites this paper
• Uncovering the mechanism of resveratrol in the treatment of diabetic kidney disease based on network pharmacology, molecular docking, and experimental validation

  2023cites this paper
• Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36/fibrosis pathway

  2023cites this paper
• Hsa_circ_0001162 Inhibition Alleviates High Glucose-Induced Human Podocytes Injury by the miR-149-5p/MMP9 Signaling Pathway

  2023cites this paper
• Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.

  2023cites this paper
• Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis.

  2022cites this paper
• Antioxidation and Nrf2-mediated heme oxygenase-1 activation contribute to renal protective effects of hydralazine in diabetic nephropathy.

  2022cites this paper
• Influence Engulfment Cell Motility-1 (ELMO-1) Protein and Matrix Metalloproteases-9 (MMP-9) in Diabetic Nephropathy Patients

  2022cites this paper
• Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes

  2022cites this paper
• Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy

  2022cites this paper
• Gene expression profile analysis unravelled the systems level association of renal cell carcinoma with diabetic nephropathy and Matrix-metalloproteinase-9 as a potential therapeutic target

  2022cites this paper
• Evaluation of Serum Levels of Tissue Inhibitor Metalloproteinase-1and Matrix Metalloproteinase-1 in Egyptian Patients with Diabetic Nephropathy

  2022cites this paper
• Development of Biomarkers and Molecular Therapy Based on Inflammatory Genes in Diabetic Nephropathy

  2021influential citation
• Epigenetic regulation of inflammatory factors in adipose tissue.

  2021cites this paper
• Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria.

  2021cites this paper
• Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy

  2021cites this paper
• Metformin mediates MicroRNA-21 regulated circulating matrix metalloproteinase-9 in diabetic nephropathy: an in-silico and clinical study

  2021cites this paper
• Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin

  2021cites this paper
• Suramin enhances the urinary excretion of VEGF-A in normoglycemic and streptozotocin-induced diabetic rats

  2021influential citation
• Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs.

  2021cites this paper
• Diabetes-related intestinal region-specific thickening of ganglionic basement membrane and regionally decreased matrix metalloproteinase 9 expression in myenteric ganglia

  2021cites this paper
• Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.

  2021cites this paper
• Serum Metabolomics Coupled with Network Pharmacology Strategy to Explore Therapeutic Effects of Scutellaria Baicalensis Georgi on Diabetic Nephropathy

  2021cites this paper
• Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease

  2021cites this paper
• Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects

  2021cites this paper
• The Interaction of Podocytes, Glomerular Cells and Mesangial Cells in Glomerulopathies

  2021cites this paper
• Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats.

  2021cites this paper
• Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

  2021cites this paper
• Identification of Hub Genes and Potential ceRNA Networks of Diabetic Nephropathy by Weighted Gene Co-Expression Network Analysis

  2021cites this paper
• GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling

  2021cites this paper
• Urinary Matrix Metalloproteinase-9 and Nephrin in Idiopathic Membranous Nephropathy: A Cross-Sectional Study

  2021cites this paper
• Sleeve Gastrectomy Attenuates Diabetic Nephropathy by Upregulating Nephrin Expressions in Diabetic Obese Rats

  2020cites this paper
• Long noncoding RNA growth arrest‐specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2

  2020cites this paper
• Matrix Metalloproteinases in Diabetic Kidney Disease

  2020cites this paper
• Systemic Inhibition of miR-451 Increases Fibrotic Signaling and Diminishes Autophagic Response to Exacerbate Renal Damage in Tallyho/Jng Mice.

  2020cites this paper
• Study on the Mechanisms of Banxia Xiexin Decoction in Treating Diabetic Gastroparesis Based on Network Pharmacology

  2020cites this paper
• Proteolytic cleavage of Podocin by Matriptase exacerbates podocyte injury

  2020cites this paper
• Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.

  2020cites this paper
• Amygdalin alleviates renal injury by suppressing inflammation, oxidative stress and fibrosis in streptozotocin-induced diabetic rats.

  2020cites this paper
• Urinary MMP-9/UCr association with albumin concentration and albumin-creatinine-ratio in Mexican patients with type 2 diabetes mellitus

  2020cites this paper
• The Anti-Apoptotic, Anti-Inflammatory And Anti- Oxidant Effects Of Olmesartan On Renal I/R Injury In Male Rat Model

  2020cites this paper
• Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease

  2019cites this paper
• metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease: Syndecan 4 in diabetic kidney disease

  2019cites this paper
• Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway.

  2019cites this paper
• syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease: Syndecan 4 in diabetic kidney

  2019cites this paper
• Genetic and Epigenetic Studies in Diabetic Kidney Disease

  2019influential citation
• Proteolytic Cleavage by Matriptase Exacerbating Kidney Injury: a Novel Therapeutic Target

  2019cites this paper
• β-N-Oxalyl-L-α,β-diaminopropionic acid from Panax notoginseng plays a major role in the treatment of type 2 diabetic nephropathy.

  2019cites this paper
• A comprehensive review on miR‐451: A promising cancer biomarker with therapeutic potential

  2019cites this paper
• Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction

  2019cites this paper
• FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy

  2019cites this paper
• Ergosterol Ameliorates Diabetic Nephropathy by Attenuating Mesangial Cell Proliferation and Extracellular Matrix Deposition via the TGF-β1/Smad2 Signaling Pathway

  2019cites this paper
• The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy

  2019cites this paper
• CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.

  2019cites this paper
• Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly

  2019cites this paper
• Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus

  2018cites this paper
• Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients With Early-stage Diabetic Nephropathy.

  2018cites this paper
• The podocyte protease web: uncovering the gatekeepers of glomerular disease.

  2018cites this paper
• Dedifferentiation and Kidney System

  2018cites this paper
• Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury

  2018cites this paper
• Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice

  2018influential citation
• Translational science in albuminuria: a new view of de novo albuminuria under chronic RAS suppression.

  2018cites this paper
• Study on the relationship between the methylation of the MMP-9 gene promoter region and diabetic nephropathy

  2018cites this paper
• Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.

  2018cites this paper
• (Pro)renin receptor is involved in mesangial fibrosis and matrix expansion

  2018cites this paper
• astragaloside iV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice

  2018influential citation
• Type 1 diabetes mellitus induces structural changes and molecular remodelling in the rat kidney

  2018cites this paper
• Systems Biology–Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes

  2017cites this paper
• Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.

  2017cites this paper
• Histamine Receptors as Drug Targets

  2017cites this paper
• Endocytosis of Albumin Induces Matrix Metalloproteinase-9 by Activating the ERK Signaling Pathway in Renal Tubule Epithelial Cells

  2017cites this paper
• First Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study

  2017cites this paper
• N-Degradomic Analysis Reveals a Proteolytic Network Processing the Podocyte Cytoskeleton.

  2017cites this paper
• Podocyte Dedifferentiation and Glomerular Injury Mediated by Lysosome Dysfunction: Role of Acid Ceramidase

  2017cites this paper
• Methodological Approaches to Study Histamine Pharmacology in the Kidney: From Cell Culture and Cell Imaging to Functional Assays and Electron Microscopy

  2017cites this paper
• Regulation of Cholesterol Homeostasis in Atherosclerosis and Alport Syndrome

  2017cites this paper
• Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.

  2017cites this paper
• Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.

  2017cites this paper
• Association of MMP-9 C-1562T polymorphism with risk of Henoch-Schönlein purpura nephritis in children of southeast China

  2017cites this paper